Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl F Hilgers

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Journal of Hypertension|March 23, 2002
Monocytes/macrophages in hypertensionKarl F Hilgers
Nature Reviews. Nephrology|July 11, 2013
Hypertension: Resistant hypertension matters in chronic kidney diseaseKarl F Hilgers
Journal of Hypertension|July 20, 2002
Angiotensin II, the endothelium and superoxide anionsKarl F Hilgers, Christian Stumpf
Journal of the American Society of Nephrology : JASN|February 11, 2005
Type 2 diabetic nephropathy: never too early to treat?Karl F Hilgers, Roland Veelken
Journal of Hypertension|October 9, 2007
Malignant hypertension and the angiotensinogen geneClaudia Handtrack, Karl F Hilgers
Journal of Hypertension|August 21, 2009
C-reactive protein: more than just a marker of inflammation?Christian Stumpf, Karl F Hilgers
Hypertension (Dallas, Tex. : 1979)|November 23, 2016
Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?Markus P Schneider, Karl F Hilgers
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[How to Retard Progression of Chronic Kidney Disease]Markus P Schneider, Karl F Hilgers
Journal of Hypertension|February 1, 2002
Association studies in cardiovascular medicineKarl F Hilgers, Roland E Schmieder
Current Opinion in Nephrology and Hypertension|January 10, 2014
What should be the goal blood pressure in nondiabetic chronic kidney disease?Markus P Schneider, Karl F Hilgers
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Journal of Hypertension|March 23, 2002
Monocytes/macrophages in hypertensionKarl F Hilgers
Nature Reviews. Nephrology|July 11, 2013
Hypertension: Resistant hypertension matters in chronic kidney diseaseKarl F Hilgers
Journal of Hypertension|July 20, 2002
Angiotensin II, the endothelium and superoxide anionsKarl F Hilgers, Christian Stumpf
Journal of the American Society of Nephrology : JASN|February 11, 2005
Type 2 diabetic nephropathy: never too early to treat?Karl F Hilgers, Roland Veelken
Journal of Hypertension|October 9, 2007
Malignant hypertension and the angiotensinogen geneClaudia Handtrack, Karl F Hilgers
Journal of Hypertension|August 21, 2009
C-reactive protein: more than just a marker of inflammation?Christian Stumpf, Karl F Hilgers
Hypertension (Dallas, Tex. : 1979)|November 23, 2016
Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?Markus P Schneider, Karl F Hilgers
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[How to Retard Progression of Chronic Kidney Disease]Markus P Schneider, Karl F Hilgers
Journal of Hypertension|February 1, 2002
Association studies in cardiovascular medicineKarl F Hilgers, Roland E Schmieder
Current Opinion in Nephrology and Hypertension|January 10, 2014
What should be the goal blood pressure in nondiabetic chronic kidney disease?Markus P Schneider, Karl F Hilgers
Pageof 13